Access the full text.
Sign up today, get DeepDyve free for 14 days.
( Jordan JT , Smith MJ , Walker JA , et al. Pain correlates with germline mutation in schwannomatosis. Medicine (Baltimore) 2018;97:e9717.29384852)
Jordan JT , Smith MJ , Walker JA , et al. Pain correlates with germline mutation in schwannomatosis. Medicine (Baltimore) 2018;97:e9717.29384852Jordan JT , Smith MJ , Walker JA , et al. Pain correlates with germline mutation in schwannomatosis. Medicine (Baltimore) 2018;97:e9717.29384852, Jordan JT , Smith MJ , Walker JA , et al. Pain correlates with germline mutation in schwannomatosis. Medicine (Baltimore) 2018;97:e9717.29384852
( Liu H , Wu Q‐F , Li J‐Y , et al. Fibroblast growth factor 7 is a nociceptive modulator secreted via large dense‐core vesicles. J Mol Cell Biol 2015;7:466–475.25782913)
Liu H , Wu Q‐F , Li J‐Y , et al. Fibroblast growth factor 7 is a nociceptive modulator secreted via large dense‐core vesicles. J Mol Cell Biol 2015;7:466–475.25782913Liu H , Wu Q‐F , Li J‐Y , et al. Fibroblast growth factor 7 is a nociceptive modulator secreted via large dense‐core vesicles. J Mol Cell Biol 2015;7:466–475.25782913, Liu H , Wu Q‐F , Li J‐Y , et al. Fibroblast growth factor 7 is a nociceptive modulator secreted via large dense‐core vesicles. J Mol Cell Biol 2015;7:466–475.25782913
( Merker VL , Bredella MA , Cai W , et al. Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. Am J Med Genet A 2014;164A:1431–1437.24664633)
Merker VL , Bredella MA , Cai W , et al. Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. Am J Med Genet A 2014;164A:1431–1437.24664633Merker VL , Bredella MA , Cai W , et al. Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. Am J Med Genet A 2014;164A:1431–1437.24664633, Merker VL , Bredella MA , Cai W , et al. Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. Am J Med Genet A 2014;164A:1431–1437.24664633
( Schulz A , Grafe P , Hagel C , et al. Neuropathies in the setting of Neurofibromatosis tumor syndromes: complexities and opportunities. Exp Neurol 2018;299:334–344.28587874)
Schulz A , Grafe P , Hagel C , et al. Neuropathies in the setting of Neurofibromatosis tumor syndromes: complexities and opportunities. Exp Neurol 2018;299:334–344.28587874Schulz A , Grafe P , Hagel C , et al. Neuropathies in the setting of Neurofibromatosis tumor syndromes: complexities and opportunities. Exp Neurol 2018;299:334–344.28587874, Schulz A , Grafe P , Hagel C , et al. Neuropathies in the setting of Neurofibromatosis tumor syndromes: complexities and opportunities. Exp Neurol 2018;299:334–344.28587874
J. Jordan, M. Smith, J. Walker, Serkan Erdin, M. Talkowski, V. Merker, V. Ramesh, W. Cai, G. Harris, M. Bredella, M. Seijo, Alessandra Suuberg, J. Gusella, S. Plotkin (2018)
Pain correlates with germline mutation in schwannomatosisMedicine, 97
V. Merker, S. Esparza, M. Smith, A. Stemmer-Rachamimov, S. Plotkin (2012)
Clinical features of schwannomatosis: a retrospective analysis of 87 patients.The oncologist, 17 10
( Li P , Zhao FU , Zhang J , et al. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. J Neurosurg Spine 2016;24:145–154.26407091)
Li P , Zhao FU , Zhang J , et al. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. J Neurosurg Spine 2016;24:145–154.26407091Li P , Zhao FU , Zhang J , et al. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. J Neurosurg Spine 2016;24:145–154.26407091, Li P , Zhao FU , Zhang J , et al. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. J Neurosurg Spine 2016;24:145–154.26407091
( Wagner R , Myers RR . Schwann cells produce tumor necrosis factor alpha: expression in injured and non‐injured nerves. Neuroscience 1996;73:625–629.8809782)
Wagner R , Myers RR . Schwann cells produce tumor necrosis factor alpha: expression in injured and non‐injured nerves. Neuroscience 1996;73:625–629.8809782Wagner R , Myers RR . Schwann cells produce tumor necrosis factor alpha: expression in injured and non‐injured nerves. Neuroscience 1996;73:625–629.8809782, Wagner R , Myers RR . Schwann cells produce tumor necrosis factor alpha: expression in injured and non‐injured nerves. Neuroscience 1996;73:625–629.8809782
( Arguis MJ , Perez J , Martinez G , et al. Contralateral neuropathic pain following a surgical model of unilateral nerve injury in rats. Reg Anesth Pain Med 2008;33:211–216.18433671)
Arguis MJ , Perez J , Martinez G , et al. Contralateral neuropathic pain following a surgical model of unilateral nerve injury in rats. Reg Anesth Pain Med 2008;33:211–216.18433671Arguis MJ , Perez J , Martinez G , et al. Contralateral neuropathic pain following a surgical model of unilateral nerve injury in rats. Reg Anesth Pain Med 2008;33:211–216.18433671, Arguis MJ , Perez J , Martinez G , et al. Contralateral neuropathic pain following a surgical model of unilateral nerve injury in rats. Reg Anesth Pain Med 2008;33:211–216.18433671
( Saydam O , Ozdener GB , Senol O , et al. A novel imaging‐compatible sciatic nerve schwannoma model. J Neurosci Methods 2011;195:75–77.21111000)
Saydam O , Ozdener GB , Senol O , et al. A novel imaging‐compatible sciatic nerve schwannoma model. J Neurosci Methods 2011;195:75–77.21111000Saydam O , Ozdener GB , Senol O , et al. A novel imaging‐compatible sciatic nerve schwannoma model. J Neurosci Methods 2011;195:75–77.21111000, Saydam O , Ozdener GB , Senol O , et al. A novel imaging‐compatible sciatic nerve schwannoma model. J Neurosci Methods 2011;195:75–77.21111000
M. Arguis, Jordi Perez, Gloria Martínez, M. Ubré, C. Gomar (2007)
Contralateral Neuropathic Pain Following a Surgical Model of Unilateral Nerve Injury in RatsRegional Anesthesia & Pain Medicine, 33
Annette Bakker, S. Rosa, L. Sherman, P. Knight, H. Lee, Patrice Pancza, M. Nievo (2017)
Neurofibromatosis as a gateway to better treatment for a variety of malignanciesProgress in Neurobiology, 152
( Evans DG . Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009;4:16.19545378)
Evans DG . Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009;4:16.19545378Evans DG . Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009;4:16.19545378, Evans DG . Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009;4:16.19545378
( Grothe C , Nikkhah G . The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat Embryol (Berl) 2001;204:171–177.11681796)
Grothe C , Nikkhah G . The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat Embryol (Berl) 2001;204:171–177.11681796Grothe C , Nikkhah G . The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat Embryol (Berl) 2001;204:171–177.11681796, Grothe C , Nikkhah G . The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat Embryol (Berl) 2001;204:171–177.11681796
( Ornitz DM , Itoh N . The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 2015;4:215–266.25772309)
Ornitz DM , Itoh N . The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 2015;4:215–266.25772309Ornitz DM , Itoh N . The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 2015;4:215–266.25772309, Ornitz DM , Itoh N . The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 2015;4:215–266.25772309
( Hargreaves K , Dubner R , Brown F , et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.3340425)
Hargreaves K , Dubner R , Brown F , et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.3340425Hargreaves K , Dubner R , Brown F , et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.3340425, Hargreaves K , Dubner R , Brown F , et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.3340425
C. Grothe, G. Nikkhah (2001)
The role of basic fibroblast growth factor in peripheral nerve regenerationAnatomy and Embryology, 204
(2008)
Orphanet Journal of Rare Diseases BioMed Central Review
( Hucho T , Levine JD . Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007;55:365–376.17678851)
Hucho T , Levine JD . Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007;55:365–376.17678851Hucho T , Levine JD . Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007;55:365–376.17678851, Hucho T , Levine JD . Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007;55:365–376.17678851
V. Merker, M. Bredella, W. Cai, A. Kassarjian, G. Harris, A. Muzikansky, R. Nguyen, V. Mautner, S. Plotkin (2014)
Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosisAmerican Journal of Medical Genetics Part A, 164
Evans DG (2009)
16Orphanet J Rare Dis, 4
Shilpa Prabhakar, Mehran Taherian, Davide Gianni, Thomas Conlon, Giulia Fulci, Jillian Brockmann, A. Stemmer-Rachamimov, M. Sena-Esteves, X. Breakefield, Gary Brenner (2013)
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.Human gene therapy, 24 2
DG Evans (2009)
Neurofibromatosis type 2 (NF2): a clinical and molecular review, 4
Arguis MJ (2008)
211Reg Anesth Pain Med, 33
( Prabhakar S , Taherian M , Gianni D , et al. Regression of schwannomas induced by adeno‐associated virus‐mediated delivery of caspase‐1. Hum Gene Ther 2013;24:152–162.23140466)
Prabhakar S , Taherian M , Gianni D , et al. Regression of schwannomas induced by adeno‐associated virus‐mediated delivery of caspase‐1. Hum Gene Ther 2013;24:152–162.23140466Prabhakar S , Taherian M , Gianni D , et al. Regression of schwannomas induced by adeno‐associated virus‐mediated delivery of caspase‐1. Hum Gene Ther 2013;24:152–162.23140466, Prabhakar S , Taherian M , Gianni D , et al. Regression of schwannomas induced by adeno‐associated virus‐mediated delivery of caspase‐1. Hum Gene Ther 2013;24:152–162.23140466
Hui Liu, Qing-Feng Wu, Jia-Yin Li, Xing-Jun Liu, Kai-Cheng Li, Y. Zhong, Dan Wu, Qiong Wang, Yin-Jing Lu, L. Bao, Xu Zhang (2015)
Fibroblast growth factor 7 is a nociceptive modulator secreted via large dense-core vesicles.Journal of molecular cell biology, 7 5
O. Saydam, Gokhan Ozdener, Ozlem Senol, Arda Mizrak, Shilpa Prabhakar, A. Stemmer-Rachamimov, X. Breakefield, G. Brenner (2011)
A novel imaging-compatible sciatic nerve schwannoma modelJournal of Neuroscience Methods, 195
T. Hucho, J. Levine (2007)
Signaling Pathways in Sensitization: Toward a Nociceptor Cell BiologyNeuron, 55
Mark Brown, Sonia Flores, R. Dubner, Margaret Hargreaves, P. Joris (1987)
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 32
R. Ji, Alexander Chamessian, Yu-Qiu Zhang (2016)
Pain regulation by non-neuronal cells and inflammationScience, 354
Peng Li, F. Zhao, Jing Zhang, Zhen-min Wang, Xingchao Wang, Bo Wang, Zhijun Yang, Jun Yang, Zhixian Gao, Pinan Liu (2016)
Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.Journal of neurosurgery. Spine, 24 1
D. Ornitz, N. Itoh (2015)
The Fibroblast Growth Factor signaling pathwayWiley Interdisciplinary Reviews. Developmental Biology, 4
( Bakker AC , La Rosa S , Sherman LS , et al. Neurofibromatosis as a gateway to better treatment for a variety of malignancies. Prog Neurogibol 2017;152:149–165.)
Bakker AC , La Rosa S , Sherman LS , et al. Neurofibromatosis as a gateway to better treatment for a variety of malignancies. Prog Neurogibol 2017;152:149–165.Bakker AC , La Rosa S , Sherman LS , et al. Neurofibromatosis as a gateway to better treatment for a variety of malignancies. Prog Neurogibol 2017;152:149–165., Bakker AC , La Rosa S , Sherman LS , et al. Neurofibromatosis as a gateway to better treatment for a variety of malignancies. Prog Neurogibol 2017;152:149–165.
Alexander Schulz, P. Grafe, C. Hagel, P. Bäumer, H. Morrison, V. Mautner, S. Farschtschi (2018)
Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunitiesExperimental Neurology, 299
( Ji RR , Chamessian A , Zhang YQ . Pain regulation by non‐neuronal cells and inflammation. Science 2016;354:572–577.27811267)
Ji RR , Chamessian A , Zhang YQ . Pain regulation by non‐neuronal cells and inflammation. Science 2016;354:572–577.27811267Ji RR , Chamessian A , Zhang YQ . Pain regulation by non‐neuronal cells and inflammation. Science 2016;354:572–577.27811267, Ji RR , Chamessian A , Zhang YQ . Pain regulation by non‐neuronal cells and inflammation. Science 2016;354:572–577.27811267
M. Furusho, J. Dupree, M. Bryant, R. Bansal (2009)
Disruption of Fibroblast Growth Factor Receptor Signaling in Nonmyelinating Schwann Cells Causes Sensory Axonal Neuropathy and Impairment of Thermal Pain SensitivityThe Journal of Neuroscience, 29
R. Wagner, R. Myers (1996)
Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nervesNeuroscience, 73
( Furusho M , Dupree JL , Bryant M , Bansal R . Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 2009;29:1608–1614.19211868)
Furusho M , Dupree JL , Bryant M , Bansal R . Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 2009;29:1608–1614.19211868Furusho M , Dupree JL , Bryant M , Bansal R . Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 2009;29:1608–1614.19211868, Furusho M , Dupree JL , Bryant M , Bansal R . Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 2009;29:1608–1614.19211868
Annals of Clinical and Translational Neurology – Wiley
Published: Jul 1, 2021
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.